
AtriCure Investor Relations Material
Latest events

Q1 2025
AtriCure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AtriCure Inc
Access all reports
AtriCure, Inc. develops, is a global company that manufactures and sells devices for the surgical ablation of cardiac tissue and systems to medical centers worldwide. It offers Isolator Synergy Ablation System for the treatment of atrial fibrillation, Isolator Synergy Access Ablation System that is used during an open surgical procedure, AtriClip LAA exclusion device that is designed to prevent stroke and AtriClip PRO that allows physicians to avoid potential complications from stitches in the heart. The company also provides EnSite Precision Cardiac Mapping System, which enables surgeons to create detailed three-dimensional models of a patient's heart during surgery.
Key slides for AtriCure Inc


Q1 2025
AtriCure Inc


Q1 2025
AtriCure Inc
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
ATRC
Country
🇺🇸 United States